Oncopeptides is a global biotech company focused on research & development of therapies for difficult-to-treat cancers

Oncopeptides AB (publ) | 10,276 followers on LinkedIn. Oncopeptides is a global biotech company focused on research & development of therapies for difficult-to-treat cancers | Oncopeptides is a biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat cancers. The company uses its proprietary Peptide Drug Candidate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells.

Pepaxti® (melphalan flufenamide, also called melflufen) has been granted Marketing Authorization, in the European Union, the EEA-countries Iceland, Lichtenstein and Norway, as well as in the UK.

Additional jobs info: Manager (1,880,925 open jobs)